Improving Mental Health Treatment Through Pharmacogenomics

RadioRev interviews CLS' President & CEO, Scott Megill

RadioRev logo

Listen here or wherever you get your podcasts: coriell.com/PGxForMentalHealth

Coriell Life Sciences’ (CLS) President and CEO, Scott Megill, joins the season 3 premiere of Icario Health‘s RadioRev to talk about pharmacogenomics (PGx) and how it relates to mental health care. In this episode, Scott discusses some of the silver linings that emerged over the last year in healthcare and pharmacogenomics in psychiatry.

Learn about:

  • CLS’ unique approach.
  • The role of personalization in CLS’ work.
  • How PGx improves mental health treatment

Learn more about pharmacogenomics and mental health.

Connect with Scott directly on LinkedIn.

Last Updated: May 4, 2023